Search

everythinglearnresearchcommunity

for

Search:↓

The document is a detailed medical reference on skin and genetic disorders.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

High glucocorticoids cause pancreatic malfunction and malabsorption, reversible with enzyme supplements.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

High levels of cortisol in hair show long-term stress which can lower fertility in animals.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Ozone and procaine boost the release of healing factors in platelet-rich plasma.

Herbal remedies can cause adverse effects and need more safety research.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Hair follicle bulge cells don't help skin regrow after glucocorticoid damage; interfollicular epidermis cells do.

The rapid corticotropin test is a quick and simple way to diagnose adrenal insufficiency.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.